Skip to main content
PLOS One logoLink to PLOS One
. 2023 Mar 15;18(3):e0282087. doi: 10.1371/journal.pone.0282087

Network analysis reveals abnormal functional brain circuitry in anxious dogs

Yangfeng Xu 1,2,‡,*, Emma Christiaen 3,, Sara De Witte 1, Qinyuan Chen 1, Kathelijne Peremans 2, Jimmy H Saunders 2, Christian Vanhove 3, Chris Baeken 1,4,5
Editor: Tamas Kozicz6
PMCID: PMC10016658  PMID: 36920933

Abstract

Anxiety is a common disease within human psychiatric disorders and has also been described as a frequently neuropsychiatric problem in dogs. Human neuroimaging studies showed abnormal functional brain networks might be involved in anxiety. In this study, we expected similar changes in network topology are also present in dogs. We performed resting-state functional MRI on 25 healthy dogs and 13 patients. The generic Canine Behavioral Assessment & Research Questionnaire was used to evaluate anxiety symptoms. We constructed functional brain networks and used graph theory to compare the differences between two groups. No significant differences in global network topology were found. However, focusing on the anxiety circuit, global efficiency and local efficiency were significantly higher, and characteristic path length was significantly lower in the amygdala in patients. We detected higher connectivity between amygdala-hippocampus, amygdala-mesencephalon, amygdala-thalamus, frontal lobe-hippocampus, frontal lobe-thalamus, and hippocampus-thalamus, all part of the anxiety circuit. Moreover, correlations between network metrics and anxiety symptoms were significant. Altered network measures in the amygdala were correlated with stranger-directed fear and excitability; altered degree in the hippocampus was related to attachment/attention seeking, trainability, and touch sensitivity; abnormal frontal lobe function was related to chasing and familiar dog aggression; attachment/attention seeking was correlated with functional connectivity between amygdala-hippocampus and amygdala-thalamus; familiar dog aggression was related to global network topology change. These findings may shed light on the aberrant topological organization of functional brain networks underlying anxiety in dogs.

Introduction

Anxiety disorders include disorders that share features of excessive fear and anxiety and related behavioral disturbances [1]. Anxiety disorders are classified as social anxiety disorder (SAD), post-traumatic stress disorder (PTSD), generalized anxiety disorder (GAD), panic disorder, and specific phobias [2]. These disabling conditions cause significant burdens to the individual and society, such as causing social relationships, suicide, and increasing healthcare costs. It has been widely reported that characteristic alterations in structural and functional connectivity (FC) are associated with anxiety [35], although the functional integrity and topological organization in such patients remains largely unclear.

Animal models are indispensable tools to unravel neurobiological mechanisms underlying anxiety disorders and their pathological variations. Change in neuronal activities in specific brain areas correlated with anxiety have been reported in primates [6], rodents [7], and dogs with pathological anxiety [8]. The investigation of the canine species could be of particular interest. It has been well accepted that dogs can be valid translational models for a number of human behavioral disorders [9]. Dogs can also develop these mental illnesses, and they are also relatively easily accessible and manageable compared to primates. Moreover, compared to rodents, dogs have a larger amount of frontal cortex. Thus, the canine species might be an appropriate model to investigate brain networks involved in anxiety, and together with other animal research, such as rodents, can be used as a model for human anxiety (and vice versa). The prevalence of anxiety disorders in the dog is high and the most encountered behavioral disorder in daily practice [10]. Moreover, they form a serious welfare problem not only for the well-being of the individual, but they also compromise the relationship with the owner leading to abandonment, rehoming, or even euthanasia. In the case of comorbid aggression, they result in safety hazards and are of public concern. It has been demonstrated that in several canine neuropsychiatric disorders, the neurobiological base has similar characteristics as its human counterparts [1113], also in dogs [14]. However, till now there is no report about rs-fMRI studies in anxious dogs, even though their emotional value to humans puts an increased demand on veterinarians to implement refined diagnostic tools and provide optimized treatment. Thus, we hypothesized that similar abnormal regional neural connectivity as in humans diagnosed with anxious behaviors could be found in anxious dogs.

Resting-state functional magnetic resonance imaging (rs-fMRI) could reveal correlated spontaneous low frequency blood oxygenation level-dependent (BOLD) fluctuations in anatomically distinct regions called “resting state networks” (RSNs), which are thought to reflect neural activity or relevant functions that occur in the grey matter [15]. Functionally connected regions can be identified, and brain networks can be detected based on statistical dependencies between the BOLD time series of brain regions of interest. There are several analysis methods available for investigating the brain organization, including seed-based correlation, independent component analysis and graph theory [16]. Graph theory has been widely applied to analyze the topological properties alterations in neuropsychiatric disorders and enabled understanding of how brain disorders affect the brain cognitions based on fundamental properties of the brain network, including anxiety, depression, schizophrenia, Alzheimer’s disease, and epilepsy [17]. In graph theory, the brain is considered a network or graph with brain regions as nodes and the relationship between the nodes as edges. The brain network can then be described and quantified using graph theoretical network metrics [18]. Specifically, nodal degree measures the degree of nodes tending to cluster together, global efficiency measures the efficiency of parallel information transfer through the network, clustering coefficient measures the efficiency of information exchange within a local subnetwork or among adjacent regions, characteristic path length measures the ability for information propagation within the network, the small-world network indicates a typical network that has similar path length but higher clustering than a random network [1820].

In this study, a combination of rs-fMRI and graph theory was used to investigate the underlying neuronal mechanisms of action of anxiety in dogs. rs-fMRI data were acquired in patient dogs with anxiety and in healthy dogs. In addition, different symptoms of anxiety were assessed using the Canine Behavioral Assessment & Research Questionnaire (C-BARQ), a canine behavioral questionnaire. The aim of this study was threefold: 1) to evaluate differences in brain network topology between healthy dogs and dogs with anxiety; 2) to identify differences in FC in regions implicated in anxiety and 3) to assess whether different symptoms of anxiety, as measured with the C-BARQ, are related to specific functional network differences. The results in dogs will benefit both veterinary medicine for anxiety-disordered animals and may serve human medicine as a natural model.

Materials & methods

Animal

Twenty-five beagle dogs were recruited as the healthy group (6 castrated males and 19 neutered females; aged between 1 and 8 years old; Table 1). These dogs were owned by the Department of Small Animals and the Department of Veterinary Medical Imaging and Small Animal Orthopedics, Ghent University. All dogs were checked every 3 months for health monitoring, spontaneous behavior in the kennel and behavioral responses in different contexts. All healthy beagle dogs were housed in groups of eight on an internal surface of 15 m2, with access to an outside area of 15 m2. The floor covering in the inner part consisted of wood shavings. Toys were given to these dogs every day and they were released to an enclosed playground twice a day. In addition, the veterinary students and animal house managers walked the dogs regularly. Furthermore, all these dogs displayed normal behavior, evaluated by both veterinarians involved and care takers of the dogs regularly (Details in S1 Text). Behavior remained impeccable over the whole study period. The patient group consisted of 13 volunteer dogs. The Ghent University Ethical Committee approved this study and all guidelines for animal welfare, imposed by the Ethical Committee, were respected (EC number, 2015–140, 2018–09, 2018–088).

Table 1. The demographic information of the control group (n = 25).

Breed Number Gender Age (month, mean ± sd)
Beagle 19 FC 47 ± 23
6 MC 64 ± 32

Patient recruitment

Based on the dog’s history, the physical examination and the questionnaires, all patient dogs were diagnosed with anxious behavior, with or without aggression, specifically towards familiar and unfamiliar people and animals. Mean problem duration of these dogs ranged from 8 months to 2 years; 6 were adopted from the shelter, 7 were raised up at home; 5 were aggressive towards people and dogs; 9 were afraid of people and dogs; 6 showed noise phobias; 4 went for behavioral therapy but failed; 3 went for drug therapy but failed. Blood samples were taken for thyroid function tests and sent to a commercial lab (Zoolyx, Aalst, Belgium) to exclude thyroid dysfunction-led behavior problems [21].

Behavior evaluation

The dog’s behavior (Fig 1) was assessed using the validated canine behavioral questionnaire filled in by the owner. The Canine Behavioral Assessment & Research Questionnaire (C-BARQ) is a standardized, behavioral evaluation tool for dog owners/guardians, handlers, and professionals. It was developed and validated by Y Hsu and J Serpell [22, 23]. It provides information concerning the dog’s behavior and temperament in 13 scales. This questionnaire contains 101 questions grouped into seven sections: training and obedience, aggression, fear and anxiety, separation-related behavior, excitability, attachment and attention seeking and miscellaneous. The responses to the questions were scored with a 5-point frequency scale or a 5-point semantic differential scale. The questionnaire was translated in Dutch.

Fig 1. Anxiety symptoms of dogs.

Fig 1

A second questionnaire was used, not validated yet, but specifically developed for current research questions at our department (personal communication K Overall [24]). This questionnaire did not include scoring and was predominantly used to get an overview of the different anxious and aggression driven reactions in different situations, including owner information, dog information, separation anxiety and noise phobia/reactivity screen, reactivity and aggression screen, stereotypical (repetitive) and ritual behavior. Like the C-BARQ, the questions were translated in Dutch.

MRI scan

All neuroimaging data were collected on a 3T Siemens Trio Tim scanner with the phased-array spine coil and a phased-array body matrix coil. The dogs were pre-medicated in a quiet room with dexmedetomidine (Dexdomitor; Orion) at 375 μg/m2 by intramuscular injection. General anesthesia was induced with 2–3 mg/kg propofol (Propovet Multidose, Abbott Laboratories) intravenously through a cephalic vein catheter. Anesthesia was maintained with isoflurane (Isoflo, Abbott Laboratories) in oxygen given to effect.

For each dog, a high-resolution T1-weighted 3D image was firstly acquired using a MP-RAGE sequence with the following parameters: repetition time (TR) = 2250 ms, echo time (TE) = 4.18 ms, matrix size = 256 × 256, field of view (FOV) = 256 × 256 mm2, flip angle = 9°, and voxel size = 1 × 1 × 1 mm3, 176 slices. Then, a rs-fMRI scan was acquired using a single-shot gradient echo planar imaging (EPI) sequence (TR/TE = 2000/27 ms, flip angle = 90°, matrix size = 64 × 64, FOV = 192 × 192 mm2, voxel size = 3 × 3 × 3 mm3; slice thickness = 3 mm without inter-slice gap; number of slices = 24). The dogs were placed headfirst and sternally in the scanner bore. After completion of the MRI acquisition, the dogs were allowed to recover.

Data analysis

Preprocessing

The rs-MRI data were preprocessed using SPM12 (https://www.fil.ion.ucl.ac.uk/spm/software/spm12/) and MRtrix3 [25]. First, images were realigned to their mean image using a least squares approach and a 6 parameter (rigid body) spatial transformation to remove motion artifacts. Next, the images were registered to an EPI template and spatially smoothed using a Gaussian kernel with a Full Width at Half Maximum of 6 mm. Afterwards, a band pass filter (0.01 Hz–0.1 Hz) was applied to remove physiological and low frequency noise. During the registration to the EPI template, differences in brain size between the dog breeds were minimized. During the processing, field inhomogeneity-related artifact correction was not performed, global white matter (WM) and cerebrospinal fluid (CSF) were not regressed [26].

Functional network construction

A parcellated atlas (adapted based on former research) [27, 28] containing 30 cortical and subcortical regions of interest (ROIs) was constructed based on the T1-weighted anatomical images of all animals using MRtrix3. Based on our former research and others’ research, we chose these regions as ROIs [8, 13, 2934]. One of the major objectives of our canine studies—in relation to similarities (or not) in brain circuits- is for instance to use the canine brain model to improve non-invasive brain stimulation methods, also in humans [3537]. These ROIs are listed in Table 2 and visualized in Fig 2A. Using a Graph Theoretical Analysis Toolbox (GRETNA) [38], the mean time series of each ROI was extracted and the Pearson correlation coefficient was calculated between each pair of ROIs. For each rs-fMRI scan, a 30 x 30 correlation matrix was obtained. Only positive weights in brain connectomes were included, and the network measures for all the nodes were computed on the weighted networks. To remove the weakest connections, thresholds based on network density (i.e., the number of remaining connections divided by the maximum number of possible connections) were applied to the correlation matrices. Thresholds were chosen to obtain network densities ranging from 20% to 50%, with a 5% interval [18, 39]. After thresholding, the correlation coefficients were Fisher r-to-z transformed to obtain a normal distribution. Then, functional networks or graphs were constructed based on the correlation matrices. In these graphs, the nodes correspond with the ROIs and the edges with the correlation coefficients [20, 38].

Table 2. Brain regions included in the parcellated atlas.
Label Region
1 Temporal lobe L
2 Parietal lobe L
3 Occipital lobe L
4 Frontal lobe L
5 Anterior cingulate gyrus L
6 Posterior cingulate gyrus L
7 Hippocampus L
8 Thalamus L
9 Caudate nucleus L
10 Piriform lobe L
11 Insular cortex L
12 Amygdala L
13 Cerebral hemisphere L
14 Vermis L
15 Temporal lobe R
16 Parietal lobe R
17 Occipital lobe R
18 Frontal lobe R
19 Anterior cingulate gyrus R
20 Posterior cingulate gyrus R
21 Hippocampus R
22 Thalamus R
23 Caudate nucleus R
24 Piriform lobe R
25 Insular cortex R
26 Amygdala R
27 Cerebral hemisphere R
28 Vermis R
29 Mesencephalon
30 Diencephalon

Note: L, left hemisphere; R, right hemisphere.

Fig 2.

Fig 2

A. Regions of interest (ROIs) overlaid on a T1 template. Only the right ROIs are visualized. The left ROIs are identical. B. Pipeline of the data analysis: 1) the mean time series of predefined ROIs are extracted from the preprocessed rs-fMRI images, 2) the Pearson correlation coefficient is calculated between the time series of each pair of ROIs, 3) for each rs-fMRI scan, a 30 x 30 correlation matrix is obtained, 4) the weakest connections are removed, 5) a functional network or graph, in which the nodes correspond with the ROIs and the edges with the correlation coefficients, is constructed based on the correlation matrix, and 6) global and nodal network metrics are calculated to quantify the network.

Graph theoretical analysis

For all graphs, several network metrics were calculated using GRETNA, both on a global (entire network) and nodal (per ROI) level. Degree or connection strength is the number of (weighted) edges connected to a node. It is a measurement of centrality and indicates how important a node is in the network. The characteristic path length (Lp) is the average number of edges connecting two nodes in the network and global efficiency (Eglob) is the average inverse path length between two nodes. These are measures of functional integration or overall communication efficiency in the network. Clustering coefficient (Cp) is the ratio of neighbors of a node that are connected to one another as well and local efficiency (Eloc) is the average inverse path length within the neighborhood of a node, i.e., the nodes connected to that node. These are measures of functional segregation or local interconnectivity [18, 40]. Small-worldness (σ) indicates a typical network that has similar path length but higher clustering than a random network [19]. Network metrics were calculated at different correlation matrix densities, from 20% to 50% density with a 5% interval, and averaged over these densities [20, 38]. The pipeline of the data analysis is shown in Fig 2B. Based on our former research [8, 13, 29, 30, 41, 42], relevant veterinary behavior medicine research [43], and human medicine [3134], we choose these five regions of interest as the anxiety circuit in this study: amygdala, frontal lobe, hippocampus, mesencephalon and thalamus. The vermis was chosen as the control region. Therefore, between-group differences in the nodal level were assessed in the regions of the anxiety circuit and vermis. The nonparametric Mann-Whitney U test was performed in the nodal level analysis to compare the between-group differences. To correct the network parameters for multiple comparisons, false discovery rate (FDR) correction was applied by using p < .05 as the significant threshold. The calculation of network measures of integration, segregation and centrality is summarized in Fig 3 [18].

Fig 3. Formulas to calculate the network measures.

Fig 3

Statistical analysis

Differences in the functional brain network were assessed on three levels. On a 1) global and 2) nodal level, group differences in degree, characteristic path length, global efficiency, clustering coefficient and local efficiency were assessed using a Mann-Whitney U test with a significance level of 0.05 after FDR correction for correcting multiple comparisons between nodes. On a 3) connection level, group differences in z-values between regions of the anxiety circuit were assessed using a Mann-Whitney U test with a significance level of 0.05 after FDR correction for correcting multiple comparisons between connections.

The nonparametric Spearman’s rank correlation coefficient between global network metrics, nodal degree, global efficiency as a measure for integration and clustering coefficient as a measure for segregation, and connection strength on the one hand, and the severity of anxiety symptoms, derived from the C-BARQ questionnaire, on the other hand, was calculated to assess whether they were related. Correlations between connection strength and anxiety symptoms were corrected for multiple comparisons using the FDR at q = 0.05.

Results

Thyroid test results

All patients’ thyroid test results were normal. The total thyroxine (T4), thyroid stimulating hormone (TSH), free triiodothyronine (fT3) and free thyroxine (fT4) were in normal ranges. Thyroglobulin test was negative in all patients (Table 3).

Table 3. Thyroid test results (n = 13).

Test item Result (mean ± sd) Reference
Total thyroxine (T4) 2.06 ± 0.37 1.0–3.2 μg/dL
Thyroid stimulating hormone (TSH) <0.058 ± 0.03 <0.55 ng/mL
Free triiodothyronine (fT3) 3.84 ± 1.28 2.5–7.8 pmol/L
Free thyroxine (fT4) 1.32 ± 0.62 0.6–3.0 ng/dL
Thyroglobulin test Negative Negative

Global network topology

Five network metrics were calculated on a global level: 1) mean degree, 2) characteristic path length, 3) global efficiency, 4) clustering coefficient, 5) local efficiency and 6) small-world (Fig 4A). No significant differences between groups could be found in these metrics using the Mann-Whitney U test. In addition, we found σ > 1 for the two groups, indicating that both patient and control groups exhibited small-world attributes.

Fig 4.

Fig 4

A. Global network metrics visualized as a boxplot with median and interquartile range. B. Nodal network metrics.

Nodal degree in the anxiety circuit

Differences in nodal degree, characteristic path length, global efficiency, clustering coefficient and local efficiency were assessed in the regions of the anxiety circuit: amygdala, frontal lobe, hippocampus, mesencephalon, and thalamus (Fig 4B). Network metrics were averaged between the left and right components of each region. In the amygdala, we found that the patient group exhibited significantly increased global efficiency and local efficiency (p = 0.007, FDR correction; p = 0.003, FDR correction, respectively), and significantly decreased characteristic path length (p = 0.006, FDR correction), compared with the control group (the network measure consistency was checked across the range of thresholds, results are provided in S1 Fig).

Individual connections in the anxiety circuit

To assess altered connection strength in the anxiety circuit, the z-values of the correlation coefficients between regions of the anxiety circuit were investigated. The z-values are the average of the intra- and interhemispheric connections between the left of right components of brain regions. If a z-value is zero, this means the correlation is below the threshold of an average of 20% to 50% network density [38]. The z-values or connection strength are significantly higher in the patient group compared to the control group for the connections amygdala-hippocampus, amygdala-mesencephalon, amygdala-thalamus, frontal lobe-hippocampus, frontal lobe-thalamus and hippocampus-thalamus (U = 77, p = 0.022; U = 87, p = 0.040; U = 81, p = 0.026; U = 64, p = 0.009; U = 78, p = 0.028 and U = 52.5, p = 0.005, respectively). The connection strength between hippocampus and mesencephalon is significantly lower in the patient group compared to the control group (U = 66, p = 0.014). The connections in the anxiety circuit that differed significantly between the patient group and the control group are shown in Fig 5.

Fig 5. Connections of the anxiety circuit that differ significantly between the patient group and control group.

Fig 5

Connections that are significantly higher in the patient group are indicated in yellow, connections that are significantly lower are indicated in blue. Abbreviations: AMG, amygdala; FL, frontal lobe; HC, hippocampus; MES, mesencephalon and THL, thalamus.

Correlations between network metrics and anxiety symptoms

The demographic information and C-BARQ scores of patients are provided in Table 4. Correlations of global network metrics, nodal degree, global efficiency and clustering coefficient, and connection strength with anxiety symptoms were assessed using Spearman’s rank correlation coefficient (Fig 6). Degree (ρ = 0.594, p = 0.049) and global efficiency (ρ = 0.583, p = 0.047) in amygdala were positively correlated with stranger-directed fear. Degree (ρ = -0.593, p = 0.042) in amygdala and connection strength (ρ = -0.781, p = 0.042) between the left and right amygdala were negatively correlated with excitability. Degree (ρ = 0.616, p = 0.033) in hippocampus and connection strength between amygdala and hippocampus (ρ = 0.758, p = 0.028) and amygdala and thalamus (ρ = 0.905, p<0.001) were positively correlated with attachment/attention-seeking behavior. Degree in the hippocampus was positively correlated with trainability (ρ = 0.579, p = 0.049) and touch sensitivity (ρ = 0.837, p = 0.001). Clustering coefficient in the frontal lobe was positively correlated with chasing (ρ = 0.784, p = 0.003). Finally, characteristic path length (ρ = -0.879, p = 0.009) was negatively correlated with familiar dog aggression and local efficiency (ρ = 0.805, p = 0.029), global efficiency (ρ = 0.879, p = 0.009), degree (ρ = 0.954, p = 0.001) in the frontal lobe and global efficiency (ρ = 0.954, p = 0.001) in frontal lobe were positively correlated with familiar dog aggression. For Trainability, the higher score means better trainability. For the rest, the higher score means worse behavior problems.

Table 4. The C-BARQ scores of patients.

No Age (m) Breed Gender Trainability Stranger-directed aggression Owner-directed aggression Dog-directed aggression Familiar dog aggression Chasing Stranger-directed fear Nonsocial fear Separation-related problems Touch sensitivity Excitability Attachment/attention-seeking Energy
1 64 Jack Russell terrier FC 1.50 0.80 0.00 2.63 0.50 3.50 1.50 1.83 0.00 0.50 2.00 1.67 2.00
2 66 Belgian shepherd MC 2.25 0.00 0.63 2.88 1.00 3.50 0.00 0.17 0.00 0.75 2.83 0.17 2.00
3 71 Galgo Espanol FC 1.75 0.00 0.38 0.00 2.50 1.75 4.00 3.83 0.13 0.25 1.17 3.00 1.00
4 64 White Swiss Shepherd FC 3.50 3.20 0.00 2.50 0.00 2.50 0.75 0.67 0.88 0.50 1.67 3.17 2.00
5 111 Akita Inu MC 2.88 1.00 0.25 1.25 ND 2.25 1.50 0.00 0.00 1.50 1.00 2.00 0.00
6 90 Labrador retriever MC 1.50 0.00 0.00 0.75 ND 1.00 3.00 2.83 0.00 0.50 2.00 0.33 0.00
7 41 Spanish water dog MC 3.63 2.30 0.00 1.00 ND 1.50 0.00 0.50 0.50 1.00 2.33 2.67 0.00
8 86 Galgo Espanol MC 0.13 0.00 0.00 4.00 0.00 1.25 3.75 3.83 0.00 0.50 1.67 0.17 1.00
9 55 Belgian shepherd FC 3.75 0.70 0.00 0.13 ND 1.00 1.50 2.67 0.00 1.00 2.33 3.67 4.00
10 98 Border collie MC 2.13 0.00 0.00 1.00 ND 2.00 0.50 2.00 0.13 1.00 2.67 1.67 1.50
11 57 American hairless terrier FC 3.75 0.00 0.00 0.75 0.50 2.25 1.75 2.67 0.00 1.25 2.00 3.67 2.00
12 151 Jack Russell terrier MC 1.38 0.30 0.25 2.50 0.00 0.25 1.25 0.67 1.88 3.25 2.67 3.00 2.00
13 39 English cocker spaniel FC 2.63 2.00 0.00 2.50 0.50 2.75 3.00 1.00 0.25 1.75 2.33 2.17 2.00

Note: FC—castrated female; MC–castrated male; ND-not detectable

Fig 6. Correlations of global network metrics, nodal degree, global efficiency and clustering coefficient, and connection strength with anxiety symptoms.

Fig 6

Data are visualized as a scatter plot with regression line and 95% confidence interval.

Discussion

Global network topology

At the global network topology level, no significant differences between groups were observed. In humans, many studies reported significant differences between healthy controls and anxiety patients: an increased AUC (area under the curve) of shortest path length and a decreased AUC of clustering coefficient were found in the patients with SAD on a global level [44]; significantly increased network segregation was observed in GAD [45], and sub-optimal brain-wide organization and integration was present in patients with GAD [46].

Interestingly, a number of studies have also failed to find any global network differences in anxiety disorders: the network structure and node centrality metrics did not differ between the SAD and healthy groups [47]; the global network strength of anxiety symptoms did not change significantly in eating disorder psychopathology before and after treatment [48]. Similarly, in our results global network topology is not significantly different in dogs with anxiety compared to healthy dogs. Nonetheless, in the regional topology level, enhanced functional integration was found, which may indicate greater resilience to focal neural damage in the brain. Brain network topological resilience has been assumed to protect the integrity of the network from pathological attack [49]. It might explain why there was no significant difference in the global level of our study. Only a few specific regions are affected, and this may not influence the global network. But it can also be directly related to anxious behavior traits. For instance, there is a considerable body of evidence that amygdala output is directly related to fear and anxiety phenotypes [50, 51].

Regional topological disorganization of functional networks in anxious dogs

In the anxiety group, characteristic path length was found to be lower and global efficiency higher in the amygdala. This might indicate that there is better communication efficiency between these regions and the rest of the network when confronted with anxiety. More strongly connected and better communication efficiency can be regarded as enhanced functional integration for information transfer between these brain regions and the rest of the network. In this study, we also detected that the local efficiency is higher in the amygdala in anxiety dogs when compared with the healthy group. This indicates that there is more clustering around the amygdala, so a better local interconnectivity in the anxious dogs. Increased local efficiency also indicates increased functional segregation in the amygdala. For connection strength between connections of the anxiety circuit, a more (efficient) communication in the patient group between amygdala-mesencephalon and amygdala-thalamus were observed. Here, the increased FC of these three regions is in line with a well-accepted hypothesis that anxiety and anxiety disorders are associated with increased or overactive functioning in the salience network [3].

Furthermore, in humans, it is reported that the default mode network (DMN) may interact with other brain networks during emotion regulation. For example, individuals with high trait anxiety demonstrate decreased FC between regions of the DMN and the frontoparietal network [52]. In this study, an increased connection strength between the frontal lobe and hippocampus was found. Interestingly, Hang X et al. reported that aberrant FC of some crucial brain regions of the DMN and the salience network might contribute to the pathophysiology of anxiety disorders in humans [53]. Correspondingly, in our current study, FC between amygdala-hippocampus, mesencephalon-hippocampus and thalamus-hippocampus was increased. Another hypothesis is that conflicting signals generated in the salience network are relayed to the frontoparietal network that implements increased cognitive control on future trials [3]. This corresponds with the increased connectivity between the frontal lobe and the thalamus in our findings.

A particular highlight of our results is the connection between the hippocampus and mesencephalon. Here, a less (efficient) communication was found between hippocampus and mesencephalon in the anxiety group. Of note, current findings indicate that the hippocampus and the mesencephalon are seen as partners in “integrative encoding”, suggesting that the neurotransmitter dopamine may be involved. This points toward an exciting synthesis among cognitive-, molecular-, and systems-level memory research with implications for clinical conditions in which dopaminergic neuromodulation is dysfunctional [54]. It has been reported that dysfunction of the hippocampus and the mesencephalon is related with high risk for psychosis in humans [55], and in rats destruction of dopaminergic neurons in the mesencephalon decreases hippocampal cell proliferation, and can be reversed by fluoxetine, suggesting fluoxetine might be potential therapeutic drugs for non-motor symptoms (e.g., anxiety, depression and cognitive deficits) in Parkinson disease [56]. Also in dogs, dopaminergic systems play an important role in determining affective reactions such as the exhibition of anxiety related behaviour problems [29, 57]. Lisman et al. developed the concept that hippocampus and midbrain dopaminergic neurons form a functional loop and proved that the enhanced connectivity between hippocampus and mesencephalon is associated with learning and information processing [58]. Thus, in our study, the lower connectivity between hippocampus and mesencephalon in the patient group may be the reason for the decreased trainability symptoms.

Correlations between network metrics and anxiety symptoms

Several tools have been developed to measure canine behavior. Some are based on the direct observation of the dog’s response to several test situations [59]. Although such tests are more objective than owner-derived information, the disadvantage is that it is difficult to evoke problem behavior in a clinical setting [60]. Other methods focus on the assessment of day-to-day behavior using a questionnaire especially designed for the dog owner. The C-BARQ is such a validated and widely used questionnaire for canine behavior.

In this study, stranger-directed fear, excitability, attachment, attention-seeking, trainability, chasing, touch sensitivity and familiar dog aggression were found to be associated with several network measures: increased FC of amygdala corresponded with more stranger-directed fear and lower excitability; increased connectivity of amygdala, hippocampus and thalamus associated with more attachment and attention-seeking behavior; increased connectivity of hippocampus correlated with a better trainability and a higher touch sensitivity; increased connectivity of frontal lobe corresponds with more chasing; increased global and local efficiency, correlated with worse familiar dog aggression; increased functional connectivity of frontal lobe also corresponded with worse familiar dog aggression.

In the dog behavior, the amygdala and hippocampus are associated with remembering things and getting aroused, excited and scared [61]. Dysfunctions of these regions can lead to anxiety symptoms like more fear, less excitability, less trainability and so on, which are in line with previous human research [62, 63]. Vermeire et al. already reported that aberrant thalamus function was observed in compulsive dogs [29]. In this study, we also observed abnormal behavior of attachment/attention-seeking is associated with the thalamus, which is consistent with previous findings of anxiety symptoms in humans [64, 65]. The findings of more chasing and worse familiar dog aggression related to the frontal lobe are also in line with human studies that found that frontal dysfunction predicts depression and anxiety symptoms [66, 67].

Limitations

Several limitations in the present study need to be considered. First, the sample size is relatively moderate. 13 dogs with different backgrounds and symptom severity might be insufficient to find global network differences. Disagreeable experience should be considered in studies examining the relationship between network differences and psychopathology [68, 69]. In this study, most patient dogs are adopted from the animal shelter, maltreatment or jettison may influence the anxiety brain networks; and a few were raised by the owners. More patients should be recruited to draw a clearer result. Second, the difference between lab and domestic dogs should be mentioned [70]. With the current data it will be impossible to disentangle the effect of ‘housing’ on the anxiety symptoms used in this cohort. We can only add to the future directions that it would be advised to research canine anxiety symptoms as well in lab animals and/or to use a more naturalistic healthy canine control group. This can be refined in the future when we have enough patients then we may draw a clear difference or consistency within the group; then beagle patients can make a more direct comparison with the control group. Third, our MRI protocol was performed under anesthesia. This might cause deviations with the awake condition. Fourth, that we have included the entire prefrontal as ROI should be considered as a limitation, given that this is a large region including subregions with potentially different functionalities in the dog anxiety system, although this is at this moment not yet established in the dog.

Conclusion

By using rs-fMRI and graph theory network analysis in dogs, we characterized abnormalities in resting-state functional brain network topology associated with anxiety. As we found correlations between anxiety symptoms and network measures, this may indicate that rs-fMRI could provide useful diagnostic information for anxiety in dogs, although further research is still required. In the future, we would also like to investigate the potential of rs-fMRI as a diagnosis tool for treatment response, such as pharmacological treatments or neural modulation treatments like rTMS. Such efforts will provide important insight into pathophysiological mechanisms of anxiety in dogs, which can lead to more personalized and effective therapies, and together with other animal research, build a bridge to the understanding of human behavior (and vice versa). Further work in larger sample sizes is needed to substantiate our observations that specific brain connectivities are associated with anxiety in dogs.

Supporting information

S1 Text. Monitoring of welfare in dogs kept and used for research purposes by the Ghent University Ethical Committee”.

(PDF)

S1 Fig. The global efficiency (a), local efficiency (b), and characteristic path length (c) of amygdala in a range of sparsity thresholds (20%-50%, with 5% intervals)”.

(DOCX)

Acknowledgments

We would like to thank the department of medical imaging and small animal orthopedics, Ghent University to provide access to their database and facilities. The authors would like to thank Ir. Gert Vanhollebeke for his excellent contribution during the revision work.

Data Availability

The dataset is available on request from the GISMO (the Integrated Research Information System of Ghent University) via gismo@ugent.be, as the dog MRI data is the property of Ghent University. A research agreement will be arranged for data share.

Funding Statement

This study is funded by Belgium governmental FWO institution (Project number G011018N). Emma Christiaen is an SB PhD fellow at Research Foundation - Flanders (Project number 1S90218N) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Asken MJ, Grossman D, Christensen LW. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Arlington, VA: American Psychiatric Pub-lishing, 2013. Archibald, Herbert C., and Read D. Tuddenham.“Persistent Stress Reac-tion after Combat: A 20-Year Follow-Up.” Archives of General Psy. Therapy. 2007;45(10):2317–25. [Google Scholar]
  • 2.Himanshu D, Deepa Sarkar N. A review of behavioral tests to evaluate different types of anxiety and anti-anxiety effects. Clinical Psychopharmacology and Neuroscience. 2020;18(3):341. doi: 10.9758/cpn.2020.18.3.341 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Sylvester CM, Corbetta M, Raichle M, Rodebaugh T, Schlaggar B, Sheline Y, et al. Functional network dysfunction in anxiety and anxiety disorders. Trends in neurosciences. 2012;35(9):527–35. doi: 10.1016/j.tins.2012.04.012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Yang X, Liu J, Meng Y, Xia M, Cui Z, Wu X, et al. Network analysis reveals disrupted functional brain circuitry in drug-naive social anxiety disorder. Neuroimage. 2019;190:213–23. doi: 10.1016/j.neuroimage.2017.12.011 [DOI] [PubMed] [Google Scholar]
  • 5.Chen AC, Etkin A. Hippocampal network connectivity and activation differentiates post-traumatic stress disorder from generalized anxiety disorder. Neuropsychopharmacology. 2013;38(10):1889–98. doi: 10.1038/npp.2013.122 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Kalin NH, Shelton SE, Fox AS, Oakes TR, Davidson RJ. Brain regions associated with the expression and contextual regulation of anxiety in primates. Biological psychiatry. 2005;58(10):796–804. doi: 10.1016/j.biopsych.2005.05.021 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Singewald N. Altered brain activity processing in high-anxiety rodents revealed by challenge paradigms and functional mapping. Neuroscience & Biobehavioral Reviews. 2007;31(1):18–40. doi: 10.1016/j.neubiorev.2006.02.003 [DOI] [PubMed] [Google Scholar]
  • 8.Vermeire S, Audenaert K, Dobbeleir A, De Meester R, Vandermeulen E, Waelbers T, et al. Regional cerebral blood flow changes in dogs with anxiety disorders, measured with SPECT. Brain Imaging and Behavior. 2009;3(4):342–9. doi: 10.1007/s11682-009-9076-1 [DOI] [Google Scholar]
  • 9.Overall KL. Natural animal models of human psychiatric conditions: assessment of mechanism and validity. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2000;24(5):727–76. doi: 10.1016/s0278-5846(00)00104-4 [DOI] [PubMed] [Google Scholar]
  • 10.Salonen M, Sulkama S, Mikkola S, Puurunen J, Hakanen E, Tiira K, et al. Prevalence, comorbidity, and breed differences in canine anxiety in 13,700 Finnish pet dogs. Scientific reports. 2020;10(1):1–11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Peremans K, Audenaert K, Coopman F, Blanckaert P, Jacobs F, Otte A, et al. Estimates of regional cerebral blood flow and 5-HT2A receptor density in impulsive, aggressive dogs with 99m Tc-ECD and 123 I-5-I-R91150. European journal of nuclear medicine and molecular imaging. 2003;30(11):1538–46. doi: 10.1007/s00259-003-1250-x [DOI] [PubMed] [Google Scholar]
  • 12.Peremans K, Audenaert K, Blanckaert P, Jacobs F, Coopman F, Verschooten F, et al. Effects of aging on brain perfusion and serotonin-2A receptor binding in the normal canine brain measured with single photon emission tomography. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2002;26(7–8):1393–404. doi: 10.1016/s0278-5846(02)00306-8 [DOI] [PubMed] [Google Scholar]
  • 13.Vermeire ST, Audenaert KR, Dobbeleir AA, De Meester RH, De Vos FJ, Peremans KY. Evaluation of the brain 5-HT2A receptor binding index in dogs with anxiety disorders, measured with 123I-5I-R91150 and SPECT. Journal of Nuclear Medicine. 2009;50(2):284–9. doi: 10.2967/jnumed.108.055731 [DOI] [PubMed] [Google Scholar]
  • 14.Szabó D, Czeibert K, Kettinger Á, Gácsi M, Andics A, Miklósi Á, et al. Resting-state fMRI data of awake dogs (Canis familiaris) via group-level independent component analysis reveal multiple, spatially distributed resting-state networks. Scientific reports. 2019;9(1):1–25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Biswal BB. Resting state fMRI: a personal history. Neuroimage. 2012;62(2):938–44. doi: 10.1016/j.neuroimage.2012.01.090 [DOI] [PubMed] [Google Scholar]
  • 16.Smitha K, Akhil Raja K, Arun K, Rajesh P, Thomas B, Kapilamoorthy T, et al. Resting state fMRI: A review on methods in resting state connectivity analysis and resting state networks. The neuroradiology journal. 2017;30(4):305–17. doi: 10.1177/1971400917697342 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Farahani FV, Karwowski W, Lighthall NR. Application of graph theory for identifying connectivity patterns in human brain networks: a systematic review. frontiers in Neuroscience. 2019;13:585. doi: 10.3389/fnins.2019.00585 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Rubinov M, Sporns O. Complex network measures of brain connectivity: Uses and interpretations. NeuroImage. 2010;52(3):1059–69. doi: 10.1016/j.neuroimage.2009.10.003 [DOI] [PubMed] [Google Scholar]
  • 19.Bassett DS, Bullmore ET. Small-world brain networks revisited. The Neuroscientist. 2017;23(5):499–516. doi: 10.1177/1073858416667720 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Wang J, Zuo X, He Y. Graph-based network analysis of resting-state functional MRI. Frontiers in systems neuroscience. 2010;4:16. doi: 10.3389/fnsys.2010.00016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Aiello SE, Moses MA, Allen DG. The Merck veterinary manual: Merck & Company, Incorporated; 2016.
  • 22.Hsu Y, Serpell JA. Development and validation of a questionnaire for measuring behavior and temperament traits in pet dogs. Journal of the American Veterinary Medical Association. 2003;223(9):1293–300. doi: 10.2460/javma.2003.223.1293 [DOI] [PubMed] [Google Scholar]
  • 23.Serpell JA, Hsu Y. Development and validation of a novel method for evaluating behavior and temperament in guide dogs. Applied animal behaviour science. 2001;72(4):347–64. doi: 10.1016/s0168-1591(00)00210-0 [DOI] [PubMed] [Google Scholar]
  • 24.Overall K. Manual of Clinical Behavioral Medicine for Dogs and Cats-E-Book: Elsevier Health Sciences; 2013.
  • 25.Tournier J-D, Smith R, Raffelt D, Tabbara R, Dhollander T, Pietsch M, et al. MRtrix3: A fast, flexible and open software framework for medical image processing and visualisation. Neuroimage. 2019;202:116137. doi: 10.1016/j.neuroimage.2019.116137 [DOI] [PubMed] [Google Scholar]
  • 26.Grajauskas LA, Frizzell T, Song X, D’Arcy RC. White matter fMRI activation cannot be treated as a nuisance regressor: Overcoming a historical blind spot. Frontiers in neuroscience. 2019;13:1024. doi: 10.3389/fnins.2019.01024 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Czeibert K, Andics A, Petneházy Ö, Kubinyi E. A detailed canine brain label map for neuroimaging analysis. Biologia Futura. 2019;70(2):112–20. doi: 10.1556/019.70.2019.14 [DOI] [PubMed] [Google Scholar]
  • 28.Nitzsche B, Boltze J, Ludewig E, Flegel T, Schmidt MJ, Seeger J, et al. A stereotaxic breed-averaged, symmetric T2w canine brain atlas including detailed morphological and volumetrical data sets. Neuroimage. 2019;187:93–103. doi: 10.1016/j.neuroimage.2018.01.066 [DOI] [PubMed] [Google Scholar]
  • 29.Vermeire S, Audenaert K, De Meester R, Vandermeulen E, Waelbers T, De Spiegeleer B, et al. Serotonin 2A receptor, serotonin transporter and dopamine transporter alterations in dogs with compulsive behaviour as a promising model for human obsessive-compulsive disorder. Psychiatry Research: Neuroimaging. 2012;201(1):78–87. doi: 10.1016/j.pscychresns.2011.06.006 [DOI] [PubMed] [Google Scholar]
  • 30.Dockx R, Baeken C, Vermeire S, Waelbers T, Xu Y, Dobbeleir A, et al. Brain SPECT in the Behaviourally Disordered Dog. PET and SPECT in Psychiatry: Springer; 2021. p. 817–39. [Google Scholar]
  • 31.Baeken C, Wu G-R, De Raedt R. Dorsomedial frontal cortical metabolic differences of comorbid generalized anxiety disorder in refractory major depression: A [18F] FDG PET brain imaging study. Journal of Affective Disorders. 2018;227:550–3. doi: 10.1016/j.jad.2017.11.066 [DOI] [PubMed] [Google Scholar]
  • 32.Baeken C, Xu Y, Wu G-R, Dockx R, Peremans K, De Raedt R. Hostility in medication-resistant major depression and comorbid generalized anxiety disorder is related to increased hippocampal–amygdala 5-HT2A receptor density. European Archives of Psychiatry and Clinical Neuroscience. 2021;271(7):1369–78. doi: 10.1007/s00406-021-01243-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Etkin A. Functional neuroanatomy of anxiety: a neural circuit perspective. Behavioral neurobiology of anxiety and its treatment. 2009:251–77. [DOI] [PubMed] [Google Scholar]
  • 34.Williams LM. Precision psychiatry: a neural circuit taxonomy for depression and anxiety. The Lancet Psychiatry. 2016;3(5):472–80. doi: 10.1016/S2215-0366(15)00579-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Dockx R, Baeken C, De Bundel D, Saunders J, Van Eeckhaut A, Peremans K. Accelerated high-frequency repetitive transcranial magnetic stimulation positively influences the behavior, monoaminergic system, and cerebral perfusion in anxious aggressive dogs: A case study. Journal of Veterinary Behavior. 2019;33:108–13. [Google Scholar]
  • 36.Dockx R, Baeken C, Duprat R, De Vos F, Saunders J, Polis I, et al. Changes in canine cerebral perfusion after accelerated high frequency repetitive transcranial magnetic stimulation (HF-rTMS): A proof of concept study. The Veterinary Journal. 2018;234:66–71. doi: 10.1016/j.tvjl.2018.02.004 [DOI] [PubMed] [Google Scholar]
  • 37.Dockx R, Peremans K, Duprat R, Vlerick L, Van Laeken N, Saunders JH, et al. Accurate external localization of the left frontal cortex in dogs by using pointer based frameless neuronavigation. PeerJ. 2017;5:e3425. doi: 10.7717/peerj.3425 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Wang J, Wang X, Xia M, Liao X, Evans A, He Y. GRETNA: a graph theoretical network analysis toolbox for imaging connectomics. Frontiers in human neuroscience. 2015;9:386. doi: 10.3389/fnhum.2015.00386 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Hallquist MN, Hillary FG. Graph theory approaches to functional network organization in brain disorders: A critique for a brave new small-world. Netw Neurosci. 2019;3(1):1–26. Epub 2019/02/23. doi: 10.1162/netn_a_00054 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Wang J, Kumar S, Chang S-F. Sequential projection learning for hashing with compact codes. 2010. [Google Scholar]
  • 41.Vermeire S, Audenaert K, De Meester R, Vandermeulen E, Waelbers T, De Spiegeleer B, et al. Neuro-imaging the serotonin 2A receptor as a valid biomarker for canine behavioural disorders. Research in Veterinary Science. 2011;91(3):465–72. doi: 10.1016/j.rvsc.2010.09.021 [DOI] [PubMed] [Google Scholar]
  • 42.Peremans K, Audenaert K, Coopman F, Blanckaert P, Jacobs F, Otte A, et al. Estimates of regional cerebral blood flow and 5-HT2A receptor density in impulsive, aggressive dogs with 99mTc-ECD and 123I-5-I-R91150. European Journal of Nuclear Medicine and Molecular Imaging. 2003;30(11):1538–46. doi: 10.1007/s00259-003-1250-x [DOI] [PubMed] [Google Scholar]
  • 43.Hecht EE, Zapata I, Alvarez CE, Gutman DA, Preuss TM, Kent M, et al. Neurodevelopmental scaling is a major driver of brain–behavior differences in temperament across dog breeds. Brain Structure and Function. 2021;226(8):2725–39. doi: 10.1007/s00429-021-02368-8 [DOI] [PubMed] [Google Scholar]
  • 44.Zhu H, Qiu C, Meng Y, Yuan M, Zhang Y, Ren Z, et al. Altered topological properties of brain networks in social anxiety disorder: a resting-state functional MRI study. Scientific reports. 2017;7(1):1–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Li C, Xia L, Ma J, Li S, Liang S, Ma X, et al. Dynamic functional abnormalities in generalized anxiety disorders and their increased network segregation of a hyperarousal brain state modulated by insomnia. Journal of affective disorders. 2019;246:338–45. doi: 10.1016/j.jad.2018.12.079 [DOI] [PubMed] [Google Scholar]
  • 46.Makovac E, Mancini M, Fagioli S, Watson DR, Meeten F, Rae CL, et al. Network abnormalities in generalized anxiety pervade beyond the amygdala-pre-frontal cortex circuit: Insights from graph theory. Psychiatry Research: Neuroimaging. 2018;281:107–16. doi: 10.1016/j.pscychresns.2018.09.006 [DOI] [PubMed] [Google Scholar]
  • 47.Heeren A, McNally RJ. Social anxiety disorder as a densely interconnected network of fear and avoidance for social situations. Cognitive Therapy and Research. 2018;42(1):103–13. [Google Scholar]
  • 48.Smith KE, Mason TB, Crosby RD, Cao L, Leonard RC, Wetterneck CT, et al. A comparative network analysis of eating disorder psychopathology and co-occurring depression and anxiety symptoms before and after treatment. Psychol Med. 2019;49(2):314–24. doi: 10.1017/S0033291718000867 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Joyce KE, Hayasaka S, Laurienti PJ. The human functional brain network demonstrates structural and dynamical resilience to targeted attack. PLoS computational biology. 2013;9(1):e1002885. doi: 10.1371/journal.pcbi.1002885 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Babaev O, Chatain CP, Krueger-Burg D. Inhibition in the amygdala anxiety circuitry. Experimental & molecular medicine. 2018;50(4):1–16. doi: 10.1038/s12276-018-0063-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Tye KM, Prakash R, Kim S-Y, Fenno LE, Grosenick L, Zarabi H, et al. Amygdala circuitry mediating reversible and bidirectional control of anxiety. Nature. 2011;471(7338):358–62. doi: 10.1038/nature09820 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Basten U, Stelzel C, Fiebach CJ. Trait anxiety modulates the neural efficiency of inhibitory control. Journal of cognitive neuroscience. 2011;23(10):3132–45. doi: 10.1162/jocn_a_00003 [DOI] [PubMed] [Google Scholar]
  • 53.Xiong H, Guo R-J, Shi H-W. Altered Default Mode Network and Salience Network Functional Connectivity in Patients with Generalized Anxiety Disorders: An ICA-Based Resting-State fMRI Study. Evidence-Based Complementary and Alternative Medicine. 2020;2020. doi: 10.1155/2020/4048916 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Kumaran D, Duzel E. The hippocampus and dopaminergic midbrain: old couple, new insights. Neuron. 2008;60(2):197–200. doi: 10.1016/j.neuron.2008.10.007 [DOI] [PubMed] [Google Scholar]
  • 55.Allen P, Chaddock CA, Egerton A, Howes OD, Bonoldi I, Zelaya F, et al. Resting hyperperfusion of the hippocampus, midbrain, and basal ganglia in people at high risk for psychosis. American Journal of Psychiatry. 2016;173(4):392–9. doi: 10.1176/appi.ajp.2015.15040485 [DOI] [PubMed] [Google Scholar]
  • 56.Suzuki K, Okada K, Wakuda T, Shinmura C, Kameno Y, Iwata K, et al. Destruction of dopaminergic neurons in the midbrain by 6-hydroxydopamine decreases hippocampal cell proliferation in rats: reversal by fluoxetine. Plos one. 2010;5(2):e9260. doi: 10.1371/journal.pone.0009260 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Riva J, Bondiolotti G, Michelazzi M, Verga M, Carenzi C. Anxiety related behavioural disorders and neurotransmitters in dogs. Applied Animal Behaviour Science. 2008;114(1–2):168–81. [Google Scholar]
  • 58.Lisman JE, Grace AA. The hippocampal-VTA loop: controlling the entry of information into long-term memory. Neuron. 2005;46(5):703–13. doi: 10.1016/j.neuron.2005.05.002 [DOI] [PubMed] [Google Scholar]
  • 59.Svartberg K, Forkman B. Personality traits in the domestic dog (Canis familiaris). Applied animal behaviour science. 2002;79(2):133–55. [Google Scholar]
  • 60.Van den Berg L, Schilder M, De Vries H, Leegwater P, Van Oost B. Phenotyping of aggressive behavior in golden retriever dogs with a questionnaire. Behavior genetics. 2006;36(6):882–902. doi: 10.1007/s10519-006-9089-0 [DOI] [PubMed] [Google Scholar]
  • 61.Berns G, editor Decoding the Canine Mind. Cerebrum: the Dana forum on brain science; 2020: Dana Foundation. [PMC free article] [PubMed]
  • 62.Lang PJ, Davis M, Öhman A. Fear and anxiety: animal models and human cognitive psychophysiology. Journal of affective disorders. 2000;61(3):137–59. doi: 10.1016/s0165-0327(00)00343-8 [DOI] [PubMed] [Google Scholar]
  • 63.Rhudy JL, Meagher MW. Fear and anxiety: divergent effects on human pain thresholds. Pain. 2000;84(1):65–75. doi: 10.1016/S0304-3959(99)00183-9 [DOI] [PubMed] [Google Scholar]
  • 64.Foo M, Freedle LR, Sani R, Fonda G. The effect of sandplay therapy on the thalamus in the treatment of generalized anxiety disorder: A case report. International Journal of Play Therapy. 2020;29(4):191. [Google Scholar]
  • 65.Kirouac GJ. The paraventricular nucleus of the thalamus as an integrating and relay node in the brain anxiety network. Frontiers in Behavioral Neuroscience. 2021;15:21. doi: 10.3389/fnbeh.2021.627633 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Perucca P, Perucca E. Identifying mutations in epilepsy genes: impact on treatment selection. Epilepsy research. 2019;152:18–30. doi: 10.1016/j.eplepsyres.2019.03.001 [DOI] [PubMed] [Google Scholar]
  • 67.Ding J, Chen H, Qiu C, Liao W, Warwick JM, Duan X, et al. Disrupted functional connectivity in social anxiety disorder: a resting-state fMRI study. Magnetic resonance imaging. 2011;29(5):701–11. doi: 10.1016/j.mri.2011.02.013 [DOI] [PubMed] [Google Scholar]
  • 68.Ohashi K, Anderson CM, Bolger EA, Khan A, McGreenery CE, Teicher MH. Childhood maltreatment is associated with alteration in global network fiber-tract architecture independent of history of depression and anxiety. Neuroimage. 2017;150:50–9. doi: 10.1016/j.neuroimage.2017.02.037 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Bruno J, Hosseini SH, Kesler S. Altered resting state functional brain network topology in chemotherapy-treated breast cancer survivors. Neurobiology of disease. 2012;48(3):329–38. doi: 10.1016/j.nbd.2012.07.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Calisi RM, Bentley GE. Lab and field experiments: Are they the same animal? Hormones and Behavior. 2009;56(1):1–10. doi: 10.1016/j.yhbeh.2009.02.010 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Tamas Kozicz

19 Apr 2022

PONE-D-22-02320Network analysis reveals abnormal functional brain circuitry in anxious dogsPLOS ONE

Dear Dr. Xu,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jun 03 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Tamas Kozicz

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf  and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter

3. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

4. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match.

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

5. Thank you for stating the following in the Acknowledgments Section of your manuscript:

“This study is funded by Belgium governmental FWO institution (Project number G011018N). Emma Christiaen is an SB PhD fellow at Research Foundation - Flanders (Project number 1S90218N).”

We note that you have provided additional information within the Acknowledgements Section that is not currently declared in your Funding Statement. Please note that funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

“NO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

Additional Editor Comments (if provided):

Dear Dr. Yangfeng Xu

Thank you for submitting your manuscript to PLOS One.

I have completed the evaluation of your manuscript. The reviewers recommend reconsideration of your manuscript following substantial revision. I invite you to resubmit your manuscript after addressing the reviewers’ comments.

When revising your manuscript, please consider all issues mentioned in the reviewers' comments carefully: please outline every change made in response to their comments and provide suitable rebuttals for any comments not addressed. Please note that your revised submission may need to be re-reviewed. 

PLOS One values your contribution and I look forward to receiving your revised manuscript.

Sincerely Yours,

Tamas Kozicz

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Xu et al. set out to investigate potential abnormalities in function brain networks in anxious dogs. They assessed network topology using resting-state fMRI scanning and graph theory to compare healthy dogs vs. patients. Overall, the study is interesting and well-written, but should be checked on occasional grammatical errors. Furthermore, I have some general questions and suggestions for further improvement.

Main:

1) The authors picked 5 brain regions to study the ‘anxiety circuit’. It would be good to include a rationale for including these regions.

Also, ‘frontal lobe’ is rather unspecific, as both rodent and human work indicates subregional specificity within the frontal cortex in the modulation of anxiety, with some subregions boosting and others suppressing anxiety. Why did the authors decide to take this rather unspecific readout?

2) Furthermore, the data don’t really convince me about the specificity of the reported effects to the anxiety circuit. Overall, effects seen in nodal network metrics are also found on the global level, but there they only fail to reach significance. As the authors run tests on all of the brain regions independent of each other, the effects on these regions are not directly compared, making that specificity cannot be claimed. Would there be a ‘control’ region that could be taken along to compare the effects against? Or could the authors maybe include all regions as within subject factor, to test whether all regions were similarly affected or whether effects were region-specific? The effects in the amygdala at least seem to be robust, and differ in same cases (clustering coefficient) from the other regions?

3) Related to point 2, is the number of comparisons made by the authors and the corrections for multiple testing that are actually performed. Whereas the authors do report on FDR correction for connection readouts and connectivity correlations, they do not correct any of the other readouts for the comparisons made. For example Fig 3B only already contains 25 comparisons, and none of them seems corrected for multiple testing. Similarly, Fig 5 reports on significant correlations that are not corrected for multiple testing, except for the connectivity readout.

Minor:

4) It is not completely clear to me what the exact rationale is for the study. Is it to better understand and treat anxiety in dogs, or to develop an animal model for anxious patients to allow for more invasive recordings/manipulations? The latter is mainly done in rodents, and if the authors think their model is superior to this, it would be good to further explain their reasoning. Currently, the MS includes both an introduction on human anxiety and that in dogs; the work might benefit from making the goal very clear and tailor the introduction and discussion towards this goal.

5) The manuscript would benefit from including a brief explanation of the distinct readouts of graph theory in a layman’s style in the introduction or results section. Terminology such as global efficiency, path length and nodal degree is difficult to grasp for non-experts, whereas the findings might also be of interest to them.

Reviewer #2: In the present manuscript, Xu et al. investigated functional brain network topology changes in anxious dogs (n=13) compared to healthy dogs (n=25). While their findings indicate no modifications at the whole brain level, the analysis focused on the anxiety circuit highlighted network topological changes at the node level, which resulted to be correlated with anxiety symptoms.

Despite I found the manuscript interesting, I have some concerns that the Authors should address.

- Did the Authors perform field inhomogeneity-related artifact correction?

- Were the global WM and CSF signal regressed in fMRI processing?

- Did the Authors check whether the brain connectomes exhibit a small-world behavior in line with current knowledge on brain networks? This should be verified considering the relative low number of nodes in the networks

- How did they deal with negative weights in brain connectomes?

- Have they checked if there are disconnected nodes in the functional connectomes after the thresholding procedure?

- Did the authors compute the network measures on the weighted or binarized networks?

- P.11, line 204, degree and strength are two different measures. Did the authors compute the degree or strength? Or Both? Throughout the manuscript they refer to the degree.

- More details, formula and related references should be reported for the computation of the network measures

- Did they compute the network measures for all the nodes or only those involved in the anxiety circuit? This should be better clarified in the methods section.

- Did the authors take into account multiple comparisons correction for the node-level analysis? Are the reported -pvalues uncorrected? I feel that some form of correction is warranted to ensure that nodes exhibiting different nodal topology do not suffer from multiple statistical tests (across different nodes and across different nodal measures).

- Why did they average left and right in node-level analysis of the anxiety circuit? It would be interesting to assess whether hemispheric differences exist

- In the conclusion section, the Authors state that “rs-fMRI could be used as a biomarker for anxiety”, I would suggest toning down this section as no conclusive evidence on this direction can be drawn from the present study. Correlation findings, especially on such a small sample, are not indicative of potential biomarkers.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2023 Mar 15;18(3):e0282087. doi: 10.1371/journal.pone.0282087.r002

Author response to Decision Letter 0


10 Aug 2022

Comments from Reviewer 1

Main:

1) The authors picked 5 brain regions to study the ‘anxiety circuit’. It would be good to include a rationale for including these regions.

Also, ‘frontal lobe’ is rather unspecific, as both rodent and human work indicates subregional specificity within the frontal cortex in the modulation of anxiety, with some subregions boosting and others suppressing anxiety. Why did the authors decide to take this rather unspecific readout?

We thank the referee for these insightful comments.

First, we picked these five regions based on our former research in behavior-disordered dogs, and the known human counterparts, since no clear information is available regarding the anxiety circuitry in dogs. To clarify, we have added following information in the method section:

Line 234-237: Based on our former research [8, 13, 26, 27, 38-40], relevant veterinary behavior medicine research [41], and human medicine [28-31], we choose these five regions of interest as the anxiety circuit in this study: amygdala, frontal lobe, hippocampus, mesencephalon, and thalamus.

For the ‘frontal lobe’, however, we must mention that, in contrast to rodents, in the anxiety canine model clearly showing behavior abnormalities little is known about specific anxiety subcircuits in the frontal cortical areas. Therefore, we had decided to not subdivide the frontal cortex, given that the frontal cortex by itself is not the focus of this research. Nevertheless, we acknowledge this as a study limitation, so we have added the following sentence to the discussion section:

Line 458-461: Fourth, that we have included the entire prefrontal as ROI should be considered as a limitation, given that this is a large region including subregions with potentially different functionalities in the dog anxiety system, although this is at this moment not yet established in the dog.

2) Furthermore, the data don’t really convince me about the specificity of the reported effects to the anxiety circuit. Overall, effects seen in nodal network metrics are also found on the global level, but there they only fail to reach significance. As the authors run tests on all of the brain regions independent of each other, the effects on these regions are not directly compared, making that specificity cannot be claimed. Would there be a ‘control’ region that could be taken along to compare the effects against? Or could the authors maybe include all regions as within subject factor, to test whether all regions were similarly affected or whether effects were region-specific? The effects in the amygdala at least seem to be robust, and differ in same cases (clustering coefficient) from the other regions?

Fair points.

As requested, we added vermis as ‘control’ region in the nodal level analysis. Therefore, between-group differences in the nodal level were assessed in the regions of anxiety circuit (including the frontal lobe, hippocampus, thalamus, amygdala, and mesencephalon), and we added the vermis as a ‘control’ region using non-parametric Mann-Whitney U test. To correct the network parameters for multiple comparisons, we applied FDR correction by using p < .05 as the significant threshold. We found that the patient group exhibited significantly increased global efficiency and local efficiency in the amygdala (p = 0.007, FDR correction; p = 0.003, FDR correction, respectively), compared with the control group. We also found that the patient group exhibited significantly decreased characteristic path length in the amygdala (p = 0.006, FDR correction), compared with the control group.

Consequently, we have revised the manuscript accordingly with these more stringent corrections.

In method section:

Line 237-243: The vermis was chosen as the control region. Therefore, between-group differences in the nodal level were assessed in the regions of the anxiety circuit and vermis. The nonparametric Mann-Whitney U test was performed in the nodal level analysis to compare the between-group differences. To correct the network parameters for multiple comparisons, false discovery rate (FDR) correction was applied by using p < .05 as the significant threshold.

In results section:

Line 288-292: In the amygdala, we found that the patient group exhibited significantly increased global efficiency and local efficiency (p = 0.007, FDR correction; p = 0.003, FDR correction, respectively), and significantly decreased characteristic path length (p = 0.006, FDR correction), compared with the control group.

3) Related to point 2, is the number of comparisons made by the authors and the corrections for multiple testing that are actually performed. Whereas the authors do report on FDR correction for connection readouts and connectivity correlations, they do not correct any of the other readouts for the comparisons made. For example Fig 3B only already contains 25 comparisons, and none of them seems corrected for multiple testing. Similarly, Fig 5 reports on significant correlations that are not corrected for multiple testing, except for the connectivity readout.

Thank you for this remark. Normally in graph analysis, we only corrected for multiple comparisons between regions, not between parameters. As we answered in point 2, at nodal level, we found that only in the amygdala, the global efficiency, local efficiency and characteristic path length were significantly different between patient and control groups. If we corrected for 25 comparisons, there were no significantly difference.

Minor:

4) It is not completely clear to me what the exact rationale is for the study. Is it to better understand and treat anxiety in dogs, or to develop an animal model for anxious patients to allow for more invasive recordings/manipulations? The latter is mainly done in rodents, and if the authors think their model is superior to this, it would be good to further explain their reasoning. Currently, the MS includes both an introduction on human anxiety and that in dogs; the work might benefit from making the goal very clear and tailor the introduction and discussion towards this goal.

The goal of this study is bifold: anxiety in dogs and natural animal model. Rodent model research is okay but does not provide a natural model as in general it is conducted on genetical, pharmacological, physical, manipulated animals.

Consequently, we have adapted some parts in the introduction and discussion.

In introduction section:

Line 69-71: Thus, dogs might be a better model to investigate the mechanisms of anxiety as the rodent research is in general conducted on genetical, pharmacological, physical, manipulated animals.

Line 115-117: The results in dogs will benefit both veterinary medicine for anxiety-disordered animals and may serve human medicine as a natural model.

In conclusion section:

Line 469-472: Such efforts will provide important insight in pathophysiological mechanisms and anxiety illness course in dogs that may lead to more personalized and effective therapies and provide a natural animal model for human medicine.

5) The manuscript would benefit from including a brief explanation of the distinct readouts of graph theory in a layman’s style in the introduction or results section. Terminology such as global efficiency, path length and nodal degree is difficult to grasp for non-experts, whereas the findings might also be of interest to them.

Agreed. We have added some information in the introduction section about graph theory parameters, and Table 3.

Line 103-109: Specifically, nodal degree measures the degree of nodes tending to cluster together, global efficiency measures the efficiency of parallel information transfer through the network, clustering coefficient measures the efficiency of information exchange within a local subnetwork or among adjacent regions, characteristic path length measures the ability for information propagation within the network, the small-worldness indicates a typical network that has similar path length but higher clustering than a random network [18-20].

Line 243-244: The calculation of network measures of integration, segregation and centrality is summarized in Table 3 [18].

Comments from Reviewer 2

1 Did the Authors perform field inhomogeneity-related artifact correction?

Thank you for this point. We didn’t perform field inhomogeneity-related artifact correction since this is not typically done during preprocessing of rsfMRI. However, we did perform 2nd order shimming before image acquisition to optimize the field homogeneity. This point has been added to the revision.

2 Were the global WM and CSF signal regressed in fMRI processing?

Good point. We did not do global WM and CSF signal regression. Regression of these signals is considered controversial, with some researchers believing that it leads to loss of information [26]. Because of this controversy, we decided not to regress out global WM and CSF signals. This point has been added to the revision.

[26] Grajauskas, L. A., Frizzell, T., Song, X., & D’Arcy, R. C. (2019). White matter fMRI activation cannot be treated as a nuisance regressor: Overcoming a historical blind spot. Frontiers in neuroscience, 13, 1024.

3 Did the Authors check whether the brain connectomes exhibit a small-world behavior in line with current knowledge on brain networks? This should be verified considering the relative low number of nodes in the networks

Thank you for this remark. The small-world metrics normalized clustering coefficient, normalized characteristic path length and small-worldness are similar to those of the macaque and mouse brain, that exhibit small-world behavior [19]. We found σ > 1 for the two groups, indicating that both patient and control groups exhibited small-world. Thus, we have added the point in the revision:

Line 230-232: Small-worldness (σ) indicates a typical network that has similar path length but higher clustering than a random network [19].

Line 279-281: In addition, we found σ > 1 for the two groups, indicating that both patient and control groups exhibited small-world attributes.

[19] Bassett, D. S., & Bullmore, E. T. (2017). Small-world brain networks revisited. The Neuroscientist, 23(5), 499-516.

4 How did they deal with negative weights in brain connectomes?

Only positive weights were included, negative weights were disregarded, as is typically done in graph theoretical analyses.

5 Have they checked if there are disconnected nodes in the functional connectomes after the thresholding procedure?

It was checked. All nodes have a degree higher than 1, so no disconnected nodes, although we still might have disconnected clusters.

6 Did the authors compute the network measures on the weighted or binarized networks?

Thanks for this point. We computed the network measures on the weighted networks. To make it clear, we have added this point in the revision.

7 P.11, line 204, degree and strength are two different measures. Did the authors compute the degree or strength? Or both? Throughout the manuscript they refer to the degree.

We computed the strength. We adapted this sentence in the revision as:

Connection strength is the number of (weighted) edges connected to a node.

8 More details, formula and related references should be reported for the computation of the network measures

We have added a new table describing the computation of the network measures in the method section.

9 Did they compute the network measures for all the nodes or only those involved in the anxiety circuit? This should be better clarified in the methods section.

We computed the network measures for all the nodes. As requested, we added this into the revision.

For remarks 1,2, 4, 6, and 9, we have added these points in the method part:

Line 194-197:

During the processing, field inhomogeneity-related artifact correction was not performed, global white matter (WM) and cerebrospinal fluid (CSF) were not regressed [26], only positive weights in brain connectomes were included, and the network measures for all the nodes were computed on the weighted networks.

10 Did the authors take into account multiple comparisons correction for the node-level analysis? Are the reported -pvalues uncorrected? I feel that some form of correction is warranted to ensure that nodes exhibiting different nodal topology do not suffer from multiple statistical tests (across different nodes and across different nodal measures).

Yes, we had corrected for multiple comparisons between nodes in the anxiety circuit. We have clarified this better in the revision.

Line 241-243:

To correct the network parameters for multiple comparisons, FDR correction was applied by using p < .05 as the significant threshold.

11 Why did they average left and right in node-level analysis of the anxiety circuit? It would be interesting to assess whether hemispheric differences exist

We didn’t assess whether hemispheric differences exist in this study. According to a rat study of our team with similar processing procedures, changes were very similar left and right (Christiaen et al., 2019). The advantage is that if there are less comparisons, less stringent correction necessary.

CHRISTIAEN, E., GOOSSENS, M.-G., RAEDT, R., DESCAMPS, B., LARSEN, L. E., CRAEY, E., CARRETTE, E., VONCK, K., BOON, P. & VANHOVE, C. 2019. Alterations in the functional brain network in a rat model of epileptogenesis: A longitudinal resting state fMRI study. Neuroimage, 202, 116144.

12 In the conclusion section, the Authors state that “rs-fMRI could be used as a biomarker for anxiety”, I would suggest toning down this section as no conclusive evidence on this direction can be drawn from the present study. Correlation findings, especially on such a small sample, are not indicative of potential biomarkers.

Indeed, the former conclusion we made was a bit ambitious. We have adapted the conclusion section in this revision:

Line 465-469: As we found correlations between anxiety symptoms and network measures, this may indicate that rs-fMRI could provide useful diagnostic information for anxiety in dogs, although further research is still required. In the future, we would also like to investigate the potential of rs-fMRI as a diagnosis tool for treatment response, such as pharmacological treatments or neural modulation treatments like rTMS.

Attachment

Submitted filename: response to reviewers.docx

Decision Letter 1

Tamas Kozicz

12 Sep 2022

PONE-D-22-02320R1Network analysis reveals abnormal functional brain circuitry in anxious dogsPLOS ONE

Dear Dr. Xu,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Oct 27 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Tamas Kozicz

Academic Editor

PLOS ONE

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: (No Response)

Reviewer #2: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: No

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: No

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors have answered most of my comments.

However, one of my previous points is not yet optimally dealt with:

"4) It is not completely clear to me what the exact rationale is for the study. Is it to better

understand and treat anxiety in dogs, or to develop an animal model for anxious

patients to allow for more invasive recordings/manipulations? The latter is mainly done

in rodents, and if the authors think their model is superior to this, it would be good to

further explain their reasoning. Currently, the MS includes both an introduction on

human anxiety and that in dogs; the work might benefit from making the goal very clear

and tailor the introduction and discussion towards this goal."

The authors state in their answer that their goal is bifold; anxiety in dogs and natural animal model. I totally agree on anxiety in dogs, but the statements on rodent research are rather blunt. Rodents may be evolutionary more distinct from humans than dogs, but the manipulations listed are not always implemented, and if applied, serve specific purposes such as targeted manipulations of cells or circuits to study their effects on behavior. Studies in dogs have other flaws; for example that there is much less knowledge to build on than in rodents, and there might be more stringent ethical restrictions to work in dogs (and less possibilities for manipulations to study causality). According to the 3R principle the work in dogs should have clear benefits over working with other animal models, to warrant their use. As such, I am not convinced by the current answer and text added to the MS. A more nuanced discusion would benefit the paper.

Reviewer #2: I thank the Authors for addressing most of my concerns. I have a few comments yet.

1. Was the C-BARQ administered both to healthy and anxious dogs?

2. Lines 196-197, I do not understand way the Authors chose to report “only positive weights in brain connectomes were included, and the network measures for all the nodes were computed on the weighted networks.” in the Preprocessing section. This explanation would better fit the section Functional network construction.

3. Did the Authors check whether the network measures were consistent across the range of thresholds explored?

4. Line 258, should “connections” read “comparisons”?

5. Was the statistical analysis at the connection level performed on the 30x30 connectivity matrix? Or did the authors extract only the connectivity patterns between the five regions of interest? Reading lines 295-296, I assume the latter. In this case, why did the Authors choose to create 30x30 connectivity matrices instead of 5x5 matrices? What is the role of the remaining brain regions? In addition, by doing this, the node-level topological measures reflect not only the of connectivity between the anxiety-related regions, but also the connectivity patterns of such regions with the remaining 25 brain areas. And this may also explain why no changes in global network topology have been identified.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2023 Mar 15;18(3):e0282087. doi: 10.1371/journal.pone.0282087.r004

Author response to Decision Letter 1


27 Oct 2022

Reviewer #1: The authors have answered most of my comments.

However, one of my previous points is not yet optimally dealt with:

"4) It is not completely clear to me what the exact rationale is for the study. Is it to better understand and treat anxiety in dogs, or to develop an animal model for anxious patients to allow for more invasive recordings/manipulations? The latter is mainly done in rodents, and if the authors think their model is superior to this, it would be good to further explain their reasoning. Currently, the MS includes both an introduction on human anxiety and that in dogs; the work might benefit from making the goal very clear and tailor the introduction and discussion towards this goal."

The authors state in their answer that their goal is bifold, anxiety in dogs and natural animal model. I totally agree on anxiety in dogs, but the statements on rodent research are rather blunt. Rodents may be evolutionary more distinct from humans than dogs, but the manipulations listed are not always implemented, and if applied, serve specific purposes such as targeted manipulations of cells or circuits to study their effects on behavior. Studies in dogs have other flaws; for example, that there is much less knowledge to build on than in rodents, and there might be more stringent ethical restrictions to work in dogs (and less possibilities for manipulations to study causality). According to the 3R principle the work in dogs should have clear benefits over working with other animal models, to warrant their use. As such, I am not convinced by the current answer and text added to the MS. A more nuanced discussion would benefit the paper.

Thank you for this useful remark. In fact, the realm of our research, is all that. It is to better understand and treat anxiety in dogs and develop an animal model. However, the referee is right that putting it all here in this manuscript is confusing, and it does not help the clarity of the paper. Of course, in this paper the goal is not to prove that dog models are superior to rodent models, as we did not include rodents in our sample.

We agree with the referee in stating that rodent models can serve better in specific purposes. We only hypothesize, that our canine model can serve as a more natural translational model, together with rodent and other animal models, which can be model for for human anxiety (and vice versa). So, we have toned town our former statement as followed:

Introduction part:

Line 70-72: Thus, the canine species might be an appropriate model to investigate brain networks involved in anxiety, and together with other animal research, such as rodents, can be used as a model for human anxiety (and vice versa).

Discussion part:

Line 470-473: Such efforts will provide important insight into pathophysiological mechanisms of anxiety in dogs, which can lead to more personalized and effective therapies, and together with other animal research, build a bridge to the understanding of human behavior (and vice versa).

Reviewer #2: I thank the Authors for addressing most of my concerns. I have a few comments yet.

1. Was the C-BARQ administered both to healthy and anxious dogs?

No, the C-BARQ was only administered to anxious dogs as mentioned in M&M-Patient recruitment. The healthy beagles got regular check by the caretakers and veterinarians, as mentioned in M&M-Animal.

2. Lines 196-197, I do not understand way the Authors chose to report “only positive weights in brain connectomes were included, and the network measures for all the nodes were computed on the weighted networks.” in the Preprocessing section. This explanation would better fit the section Functional network construction.

Good point. We have moved this to the Functional network construction section in line 208-209.

3. Did the Authors check whether the network measures were consistent across the range of thresholds explored?

No, we didn’t check. But probably the network measures were proportional to network density because of the weighted edges, as mentioned in M&M Functional network reconstruction.

4. Line 258, should “connections” read “comparisons”?

Thank you for this point. Yes, it should be “comparisons”. We have adapted it in the manuscript.

5. Was the statistical analysis at the connection level performed on the 30x30 connectivity matrix? Or did the authors extract only the connectivity patterns between the five regions of interest? Reading lines 295-296, I assume the latter. In this case, why did the Authors choose to create 30x30 connectivity matrices instead of 5x5 matrices? What is the role of the remaining brain regions? In addition, by doing this, the node-level topological measures reflect not only the of connectivity between the anxiety-related regions, but also the connectivity patterns of such regions with the remaining 25 brain areas. And this may also explain why no changes in global network topology have been identified.

Fair point. We wanted to look at the effect of anxiety on the whole brain and investigate whether whole-brain connections of the anxiety regions were affected, not just the connections in the anxiety circuit. For our graph theory application, the selected ROIs do not necessarily respect the functional boundaries of the brain [1, 2]. We did 30x30 because we assumed they are involved in anxiety, but we didn’t find global level difference, so, based on the calculated results from 30x30, we selected these 5 key regions for further analysis. On the other hand, if we would have chosen the connectivity matrices 5x5, the rest regions (25 regions) would not have been involved. This would have excluded the rest regions as potential influential nodes in the network.

[1] Yu Q, Du Y, Chen J, et al. Application of graph theory to assess static and dynamic brain connectivity: Approaches for building brain graphs[J]. Proceedings of the IEEE, 2018, 106(5): 886-906.

[2] Khullar S, Michael A M, Cahill N D, et al. ICA-fNORM: Spatial normalization of fMRI data using intrinsic group-ICA networks[J]. Frontiers in systems neuroscience, 2011, 5: 93.

Attachment

Submitted filename: Response to reviewers-20221027.docx

Decision Letter 2

Tamas Kozicz

4 Jan 2023

PONE-D-22-02320R2Network analysis reveals abnormal functional brain circuitry in anxious dogsPLOS ONE

Dear Dr. Xu,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Feb 18 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Tamas Kozicz

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments (if provided):

While all reviewers agreed that the manuscript improved, one minor issue to be addressed has remained open. Specifically, please clarify why you did not check for network measure consistency across the thresholds.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: (No Response)

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: (No Response)

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: (No Response)

Reviewer #2: No

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: (No Response)

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

Reviewer #2: The Authors have answered most of my comments.

However, one of their answer to one of my previous comments is not clear to me.

“3. Did the Authors check whether the network measures were consistent across the range of thresholds explored?

No, we didn’t check. But probably the network measures were proportional to network density because of the weighted edges, as mentioned in M&M Functional network reconstruction.”

In the main text the Authors state that “Network metrics were calculated at different correlation matrix densities, from 20% to 50% density with a 5% interval, and averaged over these densities”. If they computed the metrics why they did not check for network measure consistency across the range of thresholds? They may easily check it by plotting network measure values against thresholds. While not emerging from the text that the network measures were proportional to network density because of the weighted edges, the fact that some of the network measures may be proportional to network density does not necessarily means that the topology of the network is stable across the thresholds.

In addition, could the Authors explain how they chose the specific density range 20-50%?

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Marloes J.A.G. Henckens

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2023 Mar 15;18(3):e0282087. doi: 10.1371/journal.pone.0282087.r006

Author response to Decision Letter 2


31 Jan 2023

Response to reviewers:

We would like to thank the reviewers again for their very helpful and detailed comments.

Reviewer #2:

6. Review Comments to the Author

Reviewer #2: The Authors have answered most of my comments.

However, one of their answers to one of my previous comments is not clear to me.

“3. Did the Authors check whether the network measures were consistent across the range of thresholds explored?

In the main text the Authors state that “Network metrics were calculated at different correlation matrix densities, from 20% to 50% density with a 5% interval, and averaged over these densities”. If they computed the metrics why they did not check for network measure consistency across the range of thresholds? They may easily check it by plotting network measure values against thresholds. While not emerging from the text that the network measures were proportional to network density because of the weighted edges, the fact that some of the network measures may be proportional to network density does not necessarily means that the topology of the network is stable across the thresholds. In addition, could the Authors explain how they chose the specific density range 20-50%?

Thank you for this important comment.

The reason why we chose to specify the density range to be 20-50% is because the typical range for densities is 5-50% (standard in GRETNA), and because it is a balance between including enough regions to maintain a detailed representation of the brain while excluding noise or irrelevant voxels that could interfere with the analysis. But it is not a fixed standard [1, 2]. In our study, we did not include the lowest densities because there were no connections at the lowest densities, as indicated in the manuscript line 209-212 “To remove the weakest connections, thresholds based on network density (i.e., the number of remaining connections divided by the maximum number of possible connections) were applied to the correlation matrices.” We chose to start from 20% since then it is possible to compute network measures for this density and wanted to keep as close to the approved range by GRETNA.

And we agree with the reviewer that some of the network measures may be proportional to network density does not necessarily mean that the topology of the network is stable across the thresholds. Thus, we did the check for the consistency of the network measures across the range of thresholds in amygdala (these are the network measures described in our article), the results were shown below.

a

b

c

Fig. S1 The global efficiency (a), local efficiency (b), and characteristic path length (c) of amygdala in a range of sparsity thresholds (20%-50%, with 5% intervals)

As depicted in Fig.S1, even at low densities (20%), connections related to the amygdala are present in the surviving networks (5 regions) of 2 connections. This indicates that connectivity related to the amygdala is high and likely crucial. And starting at 35% densities, the results indicate a stable trend, which is convincing that the network measures are highly stable. In brief, the network measure consistency is stable across the range of 20% to 50% thresholds.

We added the consistency analysis results into the Supplement material and mentioned in the revised manuscript.

1. Rubinov M, Sporns O. Complex network measures of brain connectivity: Uses and interpretations. NeuroImage. 2010;52(3):1059-69. doi: https://doi.org/10.1016/j.neuroimage.2009.10.003.

2. Hallquist MN, Hillary FG. Graph theory approaches to functional network organization in brain disorders: A critique for a brave new small-world. Netw Neurosci. 2019;3(1):1-26. Epub 2019/02/23. doi: 10.1162/netn_a_00054. PubMed PMID: 30793071; PubMed Central PMCID: PMCPMC6326733.

Attachment

Submitted filename: Response to reviewers20230130.docx

Decision Letter 3

Tamas Kozicz

8 Feb 2023

Network analysis reveals abnormal functional brain circuitry in anxious dogs

PONE-D-22-02320R3

Dear Dr. Xu,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Tamas Kozicz

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Tamas Kozicz

10 Feb 2023

PONE-D-22-02320R3

Network analysis reveals abnormal functional brain circuitry in anxious dogs

Dear Dr. Xu:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Tamas Kozicz

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Text. Monitoring of welfare in dogs kept and used for research purposes by the Ghent University Ethical Committee”.

    (PDF)

    S1 Fig. The global efficiency (a), local efficiency (b), and characteristic path length (c) of amygdala in a range of sparsity thresholds (20%-50%, with 5% intervals)”.

    (DOCX)

    Attachment

    Submitted filename: response to reviewers.docx

    Attachment

    Submitted filename: Response to reviewers-20221027.docx

    Attachment

    Submitted filename: Response to reviewers20230130.docx

    Data Availability Statement

    The dataset is available on request from the GISMO (the Integrated Research Information System of Ghent University) via gismo@ugent.be, as the dog MRI data is the property of Ghent University. A research agreement will be arranged for data share.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES